Cytokinetics to Host Investor & Analyst Day on October 16, 2024 - Cytokinetics ( NASDAQ:CYTK )
Company Leadership to Discuss Cardiac Myosin Modulation, Specialty Cardiology Programs and Commercial Launch Preparations
https://www.benzinga.com/pressreleases/24/10/g41150296/cytokinetics-to-host-investor-analyst-day-on-october-16-2024